Activities of amphotericin B and antifungal azoles alone and in combination against Pseudallescheria boydii.
about
Infections caused by Scedosporium spp.Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist*In vitro activities of four novel triazoles against Scedosporium sppSynergy of nitric oxide and azoles against Candida species in vitro.Fungicidal activity of cecropin APeriocular abscess caused by Pseudallescheria boydii after a posterior subtenon injection of triamcinolone acetonide.Use of voriconazole in treatment of Scedosporium apiospermum infection: case report.Evaluation of possible correlations between antifungal susceptibilities of filamentous fungi in vitro and antifungal treatment outcomes in animal infection models.Comparison of E-test and broth microdilution methods for antifungal drug susceptibility testing of moldsAntifungal susceptibility testing: practical aspects and current challenges.In vitro interaction of terbinafine with itraconazole against clinical isolates of Scedosporium prolificans.Successful outcome of Scedosporium apiospermum disseminated infection treated with voriconazole in a patient receiving corticosteroid therapy.Antifungal triazoles and polymorphonuclear leukocytes synergize to cause increased hyphal damage to Scedosporium prolificans and Scedosporium apiospermum.Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty-first century.Has antifungal susceptibility testing come of age?Preclinical assessment of the efficacy of mycograb, a human recombinant antibody against fungal HSP90Scedosporium prolificans osteomyelitis in an immunocompetent child treated with voriconazole and caspofungin, as well as locally applied polyhexamethylene biguanideMultiple Scedosporium apiospermum abscesses in a woman survivor of a tsunami in northeastern Japan: a case report.Scedosporium species infections and treatments.Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients.Combination treatment of invasive fungal infections.Pseudallescheriasis in the 21st century.Human phagocytic cell responses to Scedosporium apiospermum (Pseudallescheria boydii): variable susceptibility to oxidative injuryMulticenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi.In vitro interaction of voriconazole and anidulafungin against triazole-resistant Aspergillus fumigatus.Scedosporium apiospermum infection after near-drowning.Emerging moulds: epidemiological trends and antifungal resistance.In vitro interaction of flucytosine combined with amphotericin B or fluconazole against thirty-five yeast isolates determined by both the fractional inhibitory concentration index and the response surface approach.Comparison of fractional inhibitory concentration index with response surface modeling for characterization of in vitro interaction of antifungals against itraconazole-susceptible and -resistant Aspergillus fumigatus isolatesKeratitis caused by Scedosporium apiospermum successfully treated with a cornea transplant and voriconazoleFilamentous fungal endophthalmitis: results of combination therapy with intravitreal amphotericin B and voriconazole.Fatal Scedosporium prolificans infection in a leukemic patient.Antifungal susceptibilities of the species of the Pseudallescheria boydii complexRefractory Scedosporium apiospermum Keratitis Successfully Treated with Combination of Amphotericin B and Voriconazole.In vitro activities of 35 double combinations of antifungal agents against Scedosporium apiospermum and Scedosporium prolificans.Deep, respiratory tract and ear infections caused by Pseudallescheria (Scedosporium) and Microascus (Scopulariopsis) in Finland. A 10-year retrospective multi-center study.Inhibition of the growth in vitro of Trichophyton mentagrophytes, Trichophyton erinacei and Microsporum persicolor by miconazole and chlorhexidine.Disseminated Pseudallescheria boydii (Scedosporium apiospermum) infection in a renal transplant patient.Synergistic inhibition of the growth in vitro of Microsporum canis by miconazole and chlorhexidine.Cure of orthopaedic infection with Scedosporium prolificans, using voriconazole plus terbinafine, without the need for radical surgery.
P2860
Q24657691-F980917E-4882-436E-ACD3-6B358D97AC38Q28315344-CF8C36DF-C425-4516-8D2F-37C92EA54484Q28366842-5F10CCF5-059A-4724-A5CC-A60613B7BBFEQ28368892-30A68755-611D-40B9-84B3-352B66538B49Q28379473-DF3E3AF8-78AE-4DA4-8BAC-89A4394FB2D8Q33239822-389C5DD3-5A54-4A64-8516-EB5C4179BA7DQ33667583-4E5F9725-DBAD-4A4F-8BFE-A8EBDC45740FQ33689568-C4D9881E-DA76-498B-B219-48A8A1280C33Q33960284-65B814F6-12C8-41AB-8E5C-BF738D726279Q33975757-CB24B452-3E03-4BD1-9AAE-AB4E788DC5CCQ33978865-5E6BCF46-04A2-4E03-9072-36998C1C912AQ34092362-D8A0A0A8-C29E-469C-8AE4-DFC11D9AC56FQ34109768-899206C9-1995-40A9-AF1C-633DB2AC9C7EQ34294875-BD1DC6E7-0D48-4285-8F2B-67B05A279515Q34923038-CFF39387-3FB2-45E0-B922-F336F4C8D015Q35102525-83C80D5A-5FD8-4944-9777-3DBE34FEDE52Q35194598-35761166-F395-4326-BBDD-770F6CD858C7Q35571541-470DC377-2922-455B-9600-EC5B1CCC20DCQ35622016-F89BAB43-FC5C-4A0E-B5FB-8F43BEE7497EQ35715408-71AEB3AA-142F-4A40-90CD-38D7A1A98B3EQ36011378-DD83D624-CED1-40A4-B681-1A4EFD6271E3Q36278064-01DC9F4C-D200-40DA-916D-5623BC30778BQ36376608-2A0E7C9F-3532-4E85-AA0A-411D84D5D8F0Q36542562-FC8BE244-1F90-4CD4-8732-7C27CBACCFD0Q36558484-3F64030C-F758-4FE3-B579-D6DDDBF52EB8Q36917112-82DECCEE-B8C4-48F0-99E8-7B7165BCD388Q37889387-787E7E96-E2D8-4BCF-AB0B-0219572B1315Q39652783-5AD66323-CC56-4CBC-B317-6F39D0413C59Q39653016-AD428434-CDFB-4519-9E8B-D2F3B35ACC26Q39751389-A11F1E39-F61C-4247-944D-BC5BDCED172EQ39803132-7FE904DF-8353-4982-A242-47C688A4FA00Q40649839-B8CEE4F5-3F7E-4233-BBAE-9D929050FE4EQ40903665-51A8BBA7-C90E-4185-B8A3-0867ACDBE74AQ41510984-7A9C167F-9818-4ECF-B306-C50898BC18D0Q41815954-06B6347D-E713-4821-8AC5-6E78F8D048B8Q43293528-54E10659-111B-4BCF-AADF-52133F8C2185Q43795829-BE51BBDD-1D2D-46F7-81AE-5C31FDACEE53Q44282956-CEB87B64-65A8-40A4-ACFD-AD4CB77AE171Q44380486-3E29815B-5E81-46AD-B5FF-1C7ACE4523A9Q44474678-37E58636-25B4-4152-BAF1-25437AE54B0C
P2860
Activities of amphotericin B and antifungal azoles alone and in combination against Pseudallescheria boydii.
description
1995 nî lūn-bûn
@nan
1995 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Activities of amphotericin B a ...... ainst Pseudallescheria boydii.
@ast
Activities of amphotericin B a ...... ainst Pseudallescheria boydii.
@en
type
label
Activities of amphotericin B a ...... ainst Pseudallescheria boydii.
@ast
Activities of amphotericin B a ...... ainst Pseudallescheria boydii.
@en
prefLabel
Activities of amphotericin B a ...... ainst Pseudallescheria boydii.
@ast
Activities of amphotericin B a ...... ainst Pseudallescheria boydii.
@en
P2093
P2860
P356
P1476
Activities of amphotericin B a ...... ainst Pseudallescheria boydii.
@en
P2093
P2860
P304
P356
10.1128/AAC.39.6.1361
P407
P577
1995-06-01T00:00:00Z